Bayer CropScienceBOM:506285 +1.11%80 EBITDA Margin % is 22.67% as of Mar. 2026, which is 24% above its 10-year median of 18.31. GuruFocus rates BOM:506285 with a GF Score™ of 80/100 and a GF Value™ of ₹5,896.56 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 247 Agriculture companies, Bayer CropScience ranks better than 78.54% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bayer CropScience's EBITDA for the
three
months ended in Mar. 2026 was ₹2,495 Mil. Bayer CropScience's Revenue for the
three
months ended in Mar. 2026 was ₹11,008 Mil. Therefore, Bayer CropScience's EBITDA margin for the quarter that ended in Mar. 2026 was 22.67%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bayer CropScience EBITDA Margin % Related Terms
Bayer CropScience EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Bayer CropScience's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:506285 vs CTVA, CF, MOS: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, Bayer CropScience's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayer CropScience EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Bayer CropScience's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bayer CropScience's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayer CropScience (BOM:506285) has a EBITDA Margin % of 22.67% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bayer CropScience and its competitors. This is 24% above median its historical median of 18.31. Over the past decade, Bayer CropScience's EBITDA Margin % has ranged from 14.79 to 22.08. According to the industry distribution chart, Bayer CropScience ranks #53 out of 247 companies in the Agriculture industry, placing it in the top 21.5%.
Is Bayer CropScience's EBITDA Margin % too high?
Bayer CropScience's current EBITDA Margin % of 22.67% is 24% above median its 10-year median of 18.31. Over the past 10 years, this metric has ranged from a low of 14.79 to a high of 22.08. The Agriculture industry median EBITDA Margin % is 9.64. Bayer CropScience's value of 22.67% is 135.2% above this industry median. Based on the distribution chart, Bayer CropScience ranks #53 out of 247 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Bayer CropScience has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bayer CropScience's EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Bayer CropScience ranks #53 out of 247 companies for EBITDA Margin %. This places Bayer CropScience in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Bayer CropScience's value of 22.67% is 135.2% above this benchmark. Historically, Bayer CropScience's own EBITDA Margin % has ranged from 14.79 to 22.08 over the past decade. While the company's 10-year median is 18.31 vs. the industry median of 9.64, Bayer CropScience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.64, based on 247 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayer CropScience's current EBITDA Margin % of 22.67% is 135.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bayer CropScience and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayer CropScience's current EBITDA Margin % is 22.67%, which is 24% above median its own 10-year median of 18.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer CropScience stock overvalued right now?
Based on GuruFocus' analysis, Bayer CropScience (BOM:506285) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5,896.56, compared to a current price of ₹4,162.70 — trading 29.4% below its estimated fair value. The current EBITDA Margin % is 22.67%, which is 24% above median its 10-year median of 18.31 and 135.2% above the Agriculture industry median of 9.64. Bayer CropScience's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bayer CropScience (BOM:506285), the current EBITDA Margin % is 22.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bayer CropScience (BOM:506285) Overvalued in 2026?
Based on GuruFocus' analysis, Bayer CropScience stock appears to be undervalued.
The current stock price of ₹4,162.70 is trading 29.4% below its estimated GF Value™ of ₹5,896.56.
GuruFocus considers Bayer CropScience to be Modestly Undervalued.
Key valuation signals for BOM:506285:
EBITDA Margin %: 22.67% (24% above median its 10-year median of 18.31)
GF Value™: ₹5,896.56 vs. price of ₹4,162.70 (29.4% below fair value)
Industry Position: 135.2% above the Agriculture median (#53 of 247)
No single metric tells the full story. See the BOM:506285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bayer CropScience Ltd manufactures, distributes, and sells crop protection and hybrid seed products to the agriculture industry. The firm sells fungicides, weedicides, hybrid seeds, consumer in-home pest-control products, and other agrochemical products. Its geographical segments are India, Germany, Bangladesh, and others, of which the vast majority of its revenue comes from India. The company is a subsidiary of Bayer AG, with the majority of common shares owned by its parent company and other Bayer AG subsidiaries.
80GF Score
Get the complete analysis for BOM:506285
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506285 has been successfully added to your 
